OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Over the last 12 months, insiders at OncoCyte Corporation have bought $11.45M and sold $0 worth of OncoCyte Corporation stock.
On average, over the past 5 years, insiders at OncoCyte Corporation have bought $12.61M and sold $73,802 worth of stock each year.
Highest buying activity among insiders over the last 12 months: BROADWOOD PARTNERS, L.P. (10 percent owner) — $43.74M. SMITH PATRICK W (10 percent owner) — $473,117. Arno Andrew (director) — $252,698.
The last purchase of 25 shares for transaction amount of $51 was made by SMITH PATRICK W (10 percent owner) on 2025‑02‑04.
2025-02-04 | 10 percent owner | 25 0.0001% | $2.02 | $51 | -2.82% | |||
2025-01-31 | 10 percent owner | 890 0.0053% | $2.01 | $1,789 | -4.61% | |||
2025-01-30 | 10 percent owner | 318 0.0019% | $2.01 | $639 | +1.72% | |||
2025-01-29 | 10 percent owner | 3,880 0.0228% | $2.01 | $7,799 | +2.26% | |||
2025-01-14 | 10 percent owner | 10,386 0.0608% | $2.15 | $22,323 | -3.72% | |||
2025-01-13 | 10 percent owner | 5,669 0.0337% | $2.08 | $11,792 | -0.48% | |||
2024-12-26 | 10 percent owner | 90,219 0.5436% | $2.13 | $192,166 | -1.41% | |||
2024-12-26 | director | 12,500 0.0745% | $2.11 | $26,350 | -1.41% | |||
2024-12-05 | Chief Financial Officer | 20,000 0.1168% | $2.29 | $45,800 | -6.09% | |||
2024-10-02 | 10 percent owner | 1.32M 9.7663% | $2.95 | $3.88M | -20.00% | |||
2024-10-02 | Chief Financial Officer | 33,670 0.2519% | $2.97 | $100,000 | -20.00% | |||
2024-04-11 | 10 percent owner | 2.42M 28.8149% | $2.92 | $7.06M | -6.06% | |||
2024-04-11 | director | 33,898 0.4083% | $2.95 | $99,999 | -6.06% | |||
2024-04-11 | CEO and President | 3,390 0.0408% | $2.95 | $10,001 | -6.06% | |||
2023-06-14 | director | 30,000 0.0246% | $0.21 | $6,447 | -30.23% | |||
2023-04-05 | 10 percent owner | 663,000 0.6681% | $0.30 | $200,027 | -37.96% | |||
2023-04-03 | 10 percent owner | 26.83M 23.0078% | $0.30 | $8.09M | -47.13% | |||
2022-12-23 | director | 250,000 0.2087% | $0.35 | $87,875 | -43.42% | |||
2022-12-23 | director | 75,000 0.0587% | $0.33 | $24,728 | -43.42% | |||
2022-12-22 | director | 25,000 0.0218% | $0.28 | $7,125 | -27.12% |
BROADWOOD PARTNERS, L.P. | 10 percent owner | 6244405 37.0914% | $1.97 | 13 | 0 | +2.24% |
SMITH PATRICK W | 10 percent owner | 1795071 10.6626% | $1.97 | 7 | 0 | |
Arno Andrew | director | 81554 0.4844% | $1.97 | 7 | 0 | <0.0001% |
James Andrea S. | Chief Financial Officer | 53670 0.3188% | $1.97 | 2 | 0 | |
Riggs Josh | CEO and President | 3505 0.0208% | $1.97 | 1 | 0 | |
BROADWOOD CAPITAL INC | 23353697 138.7195% | $1.97 | 1 | 0 | <0.0001% | |
Kamen Efrem | 8520146 50.6091% | $1.97 | 1 | 1 | <0.0001% | |
PURA VIDA INVESTMENTS, LLC | 10 percent owner | 8090202 48.0553% | $1.97 | 2 | 0 | <0.0001% |
Lineage Cell Therapeutics, Inc. | 6041154 35.8841% | $1.97 | 0 | 3 | ||
KINGSLEY ALFRED D | director | 469111 2.7865% | $1.97 | 3 | 3 | <0.0001% |
ANDREWS RONALD ASBURY | President & CEO | 333212 1.9793% | $1.97 | 8 | 0 | +1.07% |
Redmond Cavan M. | 110863 0.6585% | $1.97 | 2 | 0 | <0.0001% | |
Levine Mitchell S | Chief Financial Officer | 87080 0.5172% | $1.97 | 5 | 0 | +40.15% |
Gutfreund John Peter | director | 75000 0.4455% | $1.97 | 2 | 0 | <0.0001% |
Last Andrew J. | 70170 0.4168% | $1.97 | 2 | 0 | <0.0001% | |
Carter Jennifer L. | 30500 0.1812% | $1.97 | 1 | 0 | <0.0001% | |
GRIFFITH MELINDA | 30000 0.1782% | $1.97 | 1 | 0 | <0.0001% | |
Ross Douglas T. | Chief Scientific Officer | 20317 0.1207% | $1.97 | 1 | 0 | <0.0001% |
Yu Li | VP Cntrllr/Prncpl Acctng Offcr | 16872 0.1002% | $1.97 | 0 | 1 | |
Paulsen Gisela | Chief Operating Officer | 16500 0.098% | $1.97 | 2 | 0 | <0.0001% |
KALAJIAN TONY T | Sr.VP/Chief Accounting Officer | 15000 0.0891% | $1.97 | 2 | 0 | +163.52% |
Parker Albert P | Chief Operating Officer | 5000 0.0297% | $1.97 | 1 | 0 | +163.52% |
ANNETT WILLIAM | President and CEO | 3500 0.0208% | $1.97 | 1 | 0 | <0.0001% |
HESTERBERG LYNDAL K. | Sr VP, Research & Development | 874 0.0052% | $1.97 | 1 | 0 | <0.0001% |
Increased Positions | 4 | +14.81% | 25,675 | +0.36% |
Decreased Positions | 8 | -29.63% | 31,275 | -0.44% |
New Positions | 0 | New | 0 | New |
Sold Out Positions | 3 | Sold Out | 10,919 | Sold Out |
Total Postitions | 23 | -14.81% | 7M | -0.08% |
Broadwood Capital Inc | $10,203.00 | 29% | 4.93M | 0 | 0% | 2024-09-30 |
Awm Investment Company, Inc. | $2,271.00 | 6.45% | 1.1M | 0 | 0% | 2024-09-30 |
Pura Vida Investments, Llc | $1,025.00 | 2.91% | 495,345 | 0 | 0% | 2024-09-30 |
Vanguard Group Inc | $508.00 | 1.44% | 245,388 | +899 | +0.37% | 2024-09-30 |
Geode Capital Management, Llc | $215.00 | 0.61% | 103,980 | +11,289 | +12.18% | 2024-09-30 |
Blackrock, Inc. | $165.00 | 0.47% | 79,833 | +7,006 | +9.62% | 2024-09-30 |
Morgan Stanley | $150.00 | 0.43% | 72,289 | -6,407 | -8.14% | 2024-09-30 |
Fny Investment Advisers, Llc | $102.00 | 0.29% | 49,377 | +6,481 | +15.11% | 2024-12-31 |
Defender Capital, Llc. | $97.00 | 0.28% | 47,078 | -12,275 | -20.68% | 2024-12-31 |
State Street Corp | $40.00 | 0.12% | 19,554 | 0 | 0% | 2024-09-30 |